Skip to content

Bio-Techne TECH Operating Segments — D&A

Discontinued — last reported Q4 '16

Similar metrics at other companies

Illumina logo
ILMNOperating Segments — D&A
$39.75M+12.0%
Hasbro logo
HASOperating Segments — D&A
$31.78M
Sanmina Corp logo
SANMOperating Segments — D&A
$26.47M+6.8%
Zimmer Biomet Holdings logo
ZBHOperating Segments — D&A
$31.88M-5.8%
Builders FirstSource logo
BLDROperating Segments — D&A
$17.19M-3.0%
Fortive logo
FTVOperating Segments — D&A
$42.03M-4.0%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
Enterprise value$9.15B-13.6%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Bio-Techne’s 10-K, filed August 29, 2016, on SEC EDGAR. View the filing →

Questions, answered.

What does operating segments — D&A mean?
The non-cash expense representing the wear and tear of assets within a specific segment.
How do you interpret operating segments — D&A?
Higher levels relative to revenue may indicate a capital-intensive business model or significant recent investments in infrastructure.
How does operating segments — D&A compare across companies?
Life sciences companies with significant manufacturing footprints typically report this to show the cost of maintaining their production capabilities.